周游, 王艳林, 孙丽丹, 曹春雨, 杨建林. 新型精胺氧化酶小分子抑制剂SI-4650抗人骨肉瘤活性及分子机制研究J. 药学学报, 2019,54(3): 454-462. doi: 10.16438/j.0513-4870.2018-1055
引用本文: 周游, 王艳林, 孙丽丹, 曹春雨, 杨建林. 新型精胺氧化酶小分子抑制剂SI-4650抗人骨肉瘤活性及分子机制研究J. 药学学报, 2019,54(3): 454-462. doi: 10.16438/j.0513-4870.2018-1055
ZHOU You, WANG Yan-lin, SUN Li-dan, CAO Chun-yu, YANG Jian-lin. Anti-osteosarcoma activity and underlying molecular mechanism of a novel small molecule spermine oxidase inhibitor SI-4650J. Acta Pharmaceutica Sinica, 2019,54(3): 454-462. doi: 10.16438/j.0513-4870.2018-1055
Citation: ZHOU You, WANG Yan-lin, SUN Li-dan, CAO Chun-yu, YANG Jian-lin. Anti-osteosarcoma activity and underlying molecular mechanism of a novel small molecule spermine oxidase inhibitor SI-4650J. Acta Pharmaceutica Sinica, 2019,54(3): 454-462. doi: 10.16438/j.0513-4870.2018-1055

新型精胺氧化酶小分子抑制剂SI-4650抗人骨肉瘤活性及分子机制研究

Anti-osteosarcoma activity and underlying molecular mechanism of a novel small molecule spermine oxidase inhibitor SI-4650

  • 摘要: SI-4650是本实验室新近发现的一种新型精胺氧化酶(spermine oxidase,SMO)小分子抑制剂,本研究的目的是进一步探究SI-4650对人骨肉瘤143B细胞增殖、迁移能力的影响及其分子机制。研究利用化学发光法和高效液相色谱法分析SI-4650对143B细胞中SMO活性的影响;DIOC6(3)探针染色/流式细胞术分析细胞中活性氧的堆积水平;MTT法和流式细胞术检测SI-4650对细胞增殖和周期的影响;Transwell法和Western blot分析细胞迁移相关蛋白的表达;PI/FITC-Annexin V双染、倒置荧光显微镜观察和Western blot法分析细胞凋亡和自噬。结果显示,SI-4650可显著性抑制人骨肉瘤143B细胞内SMO酶活性,高效抑制143B细胞的增殖和迁移能力,并引起S期周期阻滞,其机制可能与干扰多胺代谢、活化线粒体介导的细胞凋亡途径和引起自噬性死亡相关。上述研究结果提示,SI-4650具有用于人骨肉瘤临床治疗的潜在价值。

     

    Abstract: The purpose of this study is to further explore the effects of SI-4650, a newly discovered small molecule inhibitor of spermine oxidase (SMO) in our laboratory, on proliferation and migration of human osteosarcoma 143B cells and its underlying molecular mechanism. Chemiluminescence and high performance liquid chromatograph were used to analyze the effect of SI-4650 on SMO activity in 143B cells. DCFH-DA-staining/FCM was used to analyze the accumulation of cellular reactive oxygen species (ROS), whereas MTT and FCM were used to detect proliferation and cell cycle. Transwell culture and Western blot were used to analyze the expression levels of migration-related proteins. PI/FITC-Annexin V/FCM, fluorescence microscopy and Western blot were used to analyze apoptosis and autophagy. Our results showed that SI-4650 could significantly decrease SMO activity, inhibit cell proliferation or migration, and induce a S-phase cell cycle arrest in 143B human osteosarcoma cells. The mechanism may be related to interfering with polyamine metabolism, activating mitochondrial-mediated apoptosis and causing autophagic death. These results suggest that SI-4650 has the potential for clinical use in treatment of osteosarcoma.

     

/

返回文章
返回